Indian government seeks to promote collaboration with stakeholders and harness potential for achieving growth and development of sector
The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
Investment proposals to the tune of Rs. 54,000 crore has been received in the healthcare and Rs. 17,000 crore has been received in medical education sector
The Survey highlighted that Indian pharmaceutical exports achieved a healthy growth of 24 per cent in FY21 and expressed hope that India’s domestic pharmaceutical market is estimated to grow to US $65 billion by 2024 from estimated US $41 billion in 2021
India is working towards augmenting health infrastructure and have initiated multiple schemes to strengthen health systems and improve health service delivery
The top 15 Indian pharma players have continued to experience anaemic growth in the US market over the five years ended FY22
The hospital will have all the modern facilities like modular OT, state of the art medical equipment, labs, etc. It will have OPD and IPD services
He urged the dignitaries to collaboratively work on the identified domains of improvement and make detailed reports on them
Subscribe To Our Newsletter & Stay Updated
